Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
A peine rentrés de vacances, les Français ont dû affronter le moment fatidique de la rentrée, et avec elle, son cortège de bonnes résolutions scolaires, sociales, politiques… et le retour pour chacun à la réalité du quotidien « métro, boulot, dodo ». Pour évaluer la place du lâcher-prise dans le quotidien des Français, Club Med, accompagné de l’Institut CSA, a voulu sonder les différentes formes d’expression que prend aujourd’hui cette notion dans la société.
Le lâcher-prise est plébiscité par plus de 8 Français sur 10 qui déclarent en ressentir le besoin tout au long de l’année, comme un moment de pause nécessaire, et 89% d’entre eux qui avouent le pratiquer sans culpabilité. Le lâcher-prise serait-il en train de faire un pied de nez à la tyrannie de l’urgence et du stress, remède imparable pour affronter nos vies agitées ?
Pour consulter le communiqué multimédia , allez à:
http://www.multivu.com/players/fr/7629751-francais-oseraient-enfin-lacher-prise/
The Clayton home building group (Clayton) and the Oak Ridge National Laboratory (ORNL) have teamed up with two other companies to design and build a 3-D printed concept home, showcasing the possibilities of 3-D printing and illustrating advancements in energy management. The four entities unveiled this revolutionary achievement in 3-D printing at a ceremony in the Oak Ridge National Laboratory on Sept. 23.
To view the multimedia release go to:
http://www.multivu.com/players/English/7413931-clayton-homes-avoid-refund-regret/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Au fil des années, Christy a mené une carrière variée en tant que mannequin, militante pour la santé maternelle, auteur, entrepreneuse, porte-parole et réalisatrice. Elle a rayonné sur de nombreux podiums et a fait la couverture de milliers de magazines, prenant la pose pour une multitude de photographes de légende pour des campagnes comme celles de Calvin Klein, Maybelline et maintenant les compléments alimentaires beauté IMEDEEN®.
Découvrez vidéo, photos et documents téléchargeables sur Christy Turlington ici: http://www.multivu.com/players/fr/7390451-christy-turlington-ambassadrice-imedeen/
(Minneapolis) January 24, 2019 – For more than 150 years, Cargill has been on an unwavering mission to nourish the world. But as the global population grows and consumer values shift, food and agriculture systems must also evolve.
“Innovation in all its forms—technology, digitalization and R&D—provides the means to address some of the greatest challenges facing the global food system,” said David MacLennan, Cargill chairman and CEO. “Whether it’s achieving zero hunger, delivering on consumer preferences, creating safer workplaces, offering transparency in our food system or helping farmers prosper, Cargill believes technology can unlock solutions.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8480151-cargill-innovation-technology/
Dos son compañía, tres son multitud y uno es el asesino. Triángulos amorosos y apasionados romances que se convierten en crímenes violentos no sólo ocurren en las telenovelas: suceden todos los días en la vida real y en ocasiones, resultan más extraños e inverosímiles que la ficción. Con intriga y suspenso, Discovery en Español investiga el lado oscuro del amor en su nueva serie PASIONES PELIGROSAS, que el canal transmitirá todos los lunes a las 10 PM E/P a partir del 30 de septiembre.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63345-discovery-en-espanol-pasiones-peligrosas-itati-cantoral
http://oolongmedia.ca/nos-services/creation-de-site-web/
Dans notre monde moderne où les gens passent de plus en plus de temps sur Internet, avoir un site Web pour une entreprise n’est plus une question, mais une nécessité. Pourtant il existe encore un certain pourcentage d’entreprise qui n’a pas encore de site Internet même si cela est presque aussi indispensable qu’avoir un numéro de téléphone. Souvent, c’est soit par manque de temps ou d’informations ou que le domaine du web n’est pas la tasse de thé des propriétaires. Dans cet article nous allons donner 10 raisons pour lesquelles toute entreprise devrait créer un site web, qu’elles soient en démarrage ou établis.
Abbott announced today the U.S. Food and Drug Administration approval and launch of the iDesign Advanced WaveScan Studio System. The system acts as the "brain" of the LASIK procedure, generating a high-definition scan that measures and maps irregularities of the eye that may impact vision. From these measurements, the iDesign System creates an accurate and personalized LASIK treatment plan based on the unique "blueprint" of each person’s eyes.
The iDesign System captures more than 1,200 micro readings of the eye, as well as identifying the shape of the cornea, its curvature, how light passes through the eye and pupil diameter under different lighting conditions – all in one, three-second scan that can be used to precisely correct vision.
The development of the sensor technology within the iDesign System was the result of an earlier discovery by Abbott scientists, which NASA used to accurately measure and shape the mirrors in the James Webb Space Telescope to ensure it will transmit high resolution images of deep space back to earth. The telescope is scheduled to launch in 2018.
To view the Multimedia News Release, please go to http://www.multivu.com/players/English/7571951-abbott-idesign-system-3-d-eye-map/
Trop d’entreprises ont un site web avec un excellent Design, mais qui est très pauvre en contenu texte. Bien que le web soit devenu une plateforme où les gens ont un laps d’attention très bref et où les vidéos et les images ont de plus en plus de place, le contenu texte n’en reste pas moins à avoir encore une place capitale. Le contenu est encore Roi. Pour le référencement web dans Google, le contenu texte (articles, de pages de ventes, blogue…) reste encore une des solutions la plus efficace et la moins coûteuse.
Cliquer ici pour plus d'information: http://oolongmedia.ca/3-aspects-indispensables-a-comprendre-avant-la-creation-dun-site-web-dentreprise
Créer un site Internet n'est pas si simple que ca. Il y a beaucoup de chose à préparer et à planifier et on commence souvent avec beaucoup de fausses informations sur la question. C'est pourquoi il est important de comprendre les implications de la création d'un site web ainsi que l'objectif de celui-ci.
INRIX®, Inc., a global leader for transportation analytics, today released its 2015 Traffic Scorecard, a benchmark for governments and agencies in the U.S. and Europe to measure progress in improving urban mobility.
The report reveals the U.S. faces large challenges to solve congestion issues, fueled by continued economic and population growth, higher employment rates and declining gas prices. Cities that have experienced the most economic improvement during the past year are at highest risk for consequences related to worsened traffic conditions, including reduced productivity, higher emissions and increased stress levels. For example, Washington D.C., San Francisco, New York, Seattle and Boston all saw reduced unemployment rates bringing them below the national average of 5.3 percent for 2015.1 However, according to the INRIX Traffic Scorecard, congestion in those cities alone combined to waste 1.5 billion hours for daily car commuters last year. Nationwide, commuters spent a total of more than eight billion extra hours stuck in traffic, representing almost 50 hours per driver.
To view the multimedia release go to:
http://www.multivu.com/players/English/7775551-inrix-2015-traffic-scorecard/
